Federated Hermes’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Federated Hermes’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,086	Closed	-$89K	–	2394
2020 Q2	$89K	Buy	+2,086	New	+$141K	﹤0.01%	1724
2020 Q1	–	Sell	-5,096	Closed	-$472K	–	2402
2019 Q4	$472K	Buy	+5,096	New	+$430K	﹤0.01%	1464
2015 Q2	–	Sell	-3,060	Closed	-$2.26M	–	2106
2015 Q1	$2.26M	Hold	3,060	–	–	0.01%	923
2014 Q4	$2.06M	Buy	+3,060	New	+$2.31M	0.01%	950

Other funds holding EVFM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Federated Hermes's EVFM Position: Q3 2020 in Review

Federated Hermes sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2020, closing a stake of 2,086 shares — an estimated $89K sold.

Federated Hermes first reported a position in EVFM in Q4 2014 and held it in 4 quarters. The position peaked at $2.26M in Q1 2015. 99 funds tracked by Wall St. Rank hold EVFM as of Q3 2020.

Federated Hermes reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Federated Hermes sold 2,086 Evofem Biosciences, Inc. Common Stock shares in Q3 2020, an estimated $89K.
Federated Hermes first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 4 quarters.
Federated Hermes's Evofem Biosciences, Inc. Common Stock position peaked at $2.26M in Q1 2015.
99 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2020.

Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.